Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial Article

Industry Collaboration International Collaboration

cited authors

  • Ledermann, Jonathan A.; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne, I; Clamp, Andrew R.; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Gancedo, Margarita Amenedo; Fong, Peter C.; Goh, Jeffrey C.; OMalley, David M.; Armstrong, Deborah K.; Banerjee, Susana; Garca-Donas, Jesus; Swisher, Elizabeth M.; Cameron, Terri; Maloney, Lara; Goble, Sandra; Coleman, Robert L.

authors

Publication Date

  • May 1, 2020

webpage

published in

category

start page

  • 710

end page

  • 722

volume

  • 21

issue

  • 5